Skip to main content
. 2017 May 26;313(2):H392–H407. doi: 10.1152/ajpheart.00124.2017

Fig. 2.

Fig. 2.

Cardiac dosimetry. A: representative serial SPECT/CT images after 125I tail vein injection at 9 wk of age (4 wk after AAV9-rNIS injection at 5 × 1010 vg). B: group data for rats injected with 5 × 1010 vg of AAV9-rNIS (n = 4) or PBS (n = 1) demonstrated time-dependent decay of cardiac 125I accumulation in AAV9-rNIS-injected rats but no cardiac accumulation in rats injected with PBS (control). C: calculation of biological cardiac half-life of 125I (see text). D: group data for the 1-h 125I uptake obtained using SPECT/CT in AAV9-rNIS-injected rats used for dosimetry and rats from the study groups to confirmed consistent NIS expression and peak 125I uptake.